These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6700412)

  • 1. [Sonographic course control of chemotherapy in inoperable pancreatic cancer].
    Braun B
    Med Welt; 1984 Jan; 35(1-2):61-6. PubMed ID: 6700412
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonging survival in inoperable pancreatic cancer with combination chemotherapy.
    Goel AK; Seenu V
    Trop Gastroenterol; 1995; 16(2):141-3. PubMed ID: 8644365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
    Gebauer T; Ridwelski K; Fahlke J; Lippert H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
    Kosakamoto H; Okada S; Ueno H; Okusaka T; Ikeda M; Tanaka N; Yoshimori M; Matsuno Y
    Hepatogastroenterology; 1999; 46(28):2621-4. PubMed ID: 10522052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.
    Han GH; Yin ZX; Meng XJ; He CY; Zhang HB; Sun AH; Wu KC; Ding J; Fan DM
    Chin J Dig Dis; 2006; 7(1):45-8. PubMed ID: 16412037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of inoperable pancreatic neoplasms with regional infusion of antineoplastic agents under ultrasonic visualization].
    Odaka M; Ryu M; Sato H
    Nihon Rinsho; 1982; 40(1):191-7. PubMed ID: 7087202
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
    Beger HG; Link KH; Gansauge F
    Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical results and indications for adjuvant measures in pancreatic cancer].
    Beger HG; Büchler MW; Friess H
    Chirurg; 1994 Apr; 65(4):246-52. PubMed ID: 7912665
    [No Abstract]   [Full Text] [Related]  

  • 12. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer.
    Ina S; Tani M; Kawai M; Hirono S; Miyazawa M; Nishioka R; Fujita Y; Yamaue H
    Anticancer Res; 2008; 28(4C):2373-7. PubMed ID: 18751421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional chemotherapy for inoperable pancreatic carcinoma.
    Muchmore JH; Preslan JE; George WJ
    Cancer; 1996 Aug; 78(3 Suppl):664-73. PubMed ID: 8681305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The first report from Sapporo Tsukisamu Hospital--chemotherapy and chemoradiotherapy for patients with advanced pancreatic cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Koito K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1059-66. PubMed ID: 17637542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy following resection for pancreatic adenocarcinoma.
    Brennan MF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
    Kuramochi H; Hayashi K; Uchida K; Nakajima G; Hatori T; Danenberg KD; Danenberg PV; Yamamoto M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):85-9. PubMed ID: 18309485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
    Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
    Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.